Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian Bahr(National Cancer Institute), Susan E. Bates(New York Oncology Hematology)
Cited by 15
Related Papers
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
|Cellular and Molecular Life Sciences|2001|685
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
|Drug Metabolism and Disposition|2010|216
Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin
|Molecular Oncology|2014|49
R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
|Molecular Cancer Research|2021|30